Featured Research

from universities, journals, and other organizations

Alzheimer's Found To Be Mostly Genetic: Largest Twin Study Ever Undertaken Confirms Highest Estimates Of Genetic Risk

Date:
February 7, 2006
Source:
University of Southern California
Summary:
Alzheimer disease has a genetic cause in up to 80 percent of cases, according to a USC-led study of nearly 12,000 twin pairs. The study appears in the February 2006 issue of Archives of General Psychiatry, a journal of the American Medical Association.

Alzheimer disease has a genetic cause in up to 80 percent of cases, according to a University of Southern California- led study of nearly 12,000 twin pairs.

The study appears in the February 2006 issue of Archives of General Psychiatry, a journal of the American Medical Association.

Margaret Gatz, professor of psychology in the USC College of Letters, Arts, and Sciences, led an international team of researchers from Gφteborg University, Jφnkφping University and Karolinska Institutet in Sweden, as well as from USC, the University of California at Riverside and the University of South Florida.

Past estimates of Alzheimer's risk varied widely, with the highest numbers sometimes greeted with skepticism.

"Our finding confirms the higher estimates that have been suggested previously. The important thing is that no one has had this large a sample before," Gatz said, adding the size was 10 times that of any previous study.

The study raises doubts about the widely held view that Alzheimer's has two forms: the "familial," with genetic roots, and the "sporadic," with environmental causes.

"In essence what we're doing is taking the folks who would have formerly been called sporadic, and testing how important genetic influences are ... and we're finding genetic influences are tremendously important," Gatz said. "It does suggest that there is an underlying genetic basis."

Gatz warned, "This doesn't mean that environment is not important. Environment may be relevant not only for whether but also for when one gets the disease. Also, you can't go from these results to any one individual."

Even identical twins, who share all their genes, differ in their vulnerability. The study found only a 45 percent concordance rate for identical male pairs. This means that of all pairs where one twin has Alzheimer's, 55 percent of the healthy twins either will never get the disease or will develop it later in life.

In her previous research with twins, Gatz identified possible preventive or delaying factors, such as a low incidence of inflammatory disease or a work environment with a high degree of human interaction.

The sample for the study consisted of all participants in the Swedish Twin Registry aged 65 or older in 1998 - the year the study began -- for a total of 11,884 twin pairs.

Of these, 392 pairs showed evidence of Alzheimer's in at least one twin.

In the model that best fit the data, genetic influence accounted for 79 percent of Alzheimer's risk, with 95 percent confidence in a range of 67 to 88 percent.

The other 21 percent of Alzheimer's risk was due to non- shared environmental causes. Risk from shared environments, such as childhood settings that were the same for both twins, was statistically negligible.

Genetic risk for Alzheimer's was the same for men and women after controlling for age.

The study is notable for its careful approach to Alzheimer's diagnosis. All individuals were screened for cognitive dysfunction. Suspected cases of dementia, of which Alzheimer's is the most common form, received complete, in-home clinical diagnostic evaluations by a doctor and nurse. Autopsy confirmation of diagnoses is being collected.

The research for this study was supported by grants from the National Institute on Aging and the Alzheimer's Association.

The other USC researcher on the study was co-principal investigator Nancy Pedersen, a research professor with a joint appointment as professor at Karolinska Institutet.


Story Source:

The above story is based on materials provided by University of Southern California. Note: Materials may be edited for content and length.


Cite This Page:

University of Southern California. "Alzheimer's Found To Be Mostly Genetic: Largest Twin Study Ever Undertaken Confirms Highest Estimates Of Genetic Risk." ScienceDaily. ScienceDaily, 7 February 2006. <www.sciencedaily.com/releases/2006/02/060206232300.htm>.
University of Southern California. (2006, February 7). Alzheimer's Found To Be Mostly Genetic: Largest Twin Study Ever Undertaken Confirms Highest Estimates Of Genetic Risk. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/02/060206232300.htm
University of Southern California. "Alzheimer's Found To Be Mostly Genetic: Largest Twin Study Ever Undertaken Confirms Highest Estimates Of Genetic Risk." ScienceDaily. www.sciencedaily.com/releases/2006/02/060206232300.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins